The intact postsynaptic protein neurogranin is reduced in brain tissue from patients with familial and sporadic Alzheimer’s disease

被引:0
|
作者
Hlin Kvartsberg
Tammaryn Lashley
Christina E. Murray
Gunnar Brinkmalm
Nicholas C. Cullen
Kina Höglund
Henrik Zetterberg
Kaj Blennow
Erik Portelius
机构
[1] The Sahlgrenska Academy at the University of Gothenburg,Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology
[2] Sahlgrenska University Hospital/Mölndal,Queen Square Brain Bank for Neurological Disorders, Department of Movement Disorders
[3] UCL Institute of Neurology,Department of Neurodegenerative Disease
[4] UCL Institute of Neurology,Clinical Neurochemistry Laboratory
[5] UK Dementia Research Institute at UCL,Department of Neurobiology, Care Sciences and Society, Center for Alzheimer Disease Research, Neurogeriatrics Division
[6] Sahlgrenska University Hospital,undefined
[7] Karolinska Institutet,undefined
来源
Acta Neuropathologica | 2019年 / 137卷
关键词
Neurogranin; Alzheimer’s disease; Brain tissue; Familial Alzheimer’s disease; Mass spectrometry;
D O I
暂无
中图分类号
学科分类号
摘要
Synaptic degeneration and neuronal loss are early events in Alzheimer’s disease (AD), occurring long before symptom onset, thus making synaptic biomarkers relevant for enabling early diagnosis. The postsynaptic protein neurogranin (Ng) is a cerebrospinal fluid (CSF) biomarker for AD, also in the prodromal phase. Here we tested the hypothesis that during AD neurodegeneration, processing of full-length Ng into endogenous peptides in the brain is increased. We characterized Ng in post-mortem brain tissue and investigated the levels of endogenous Ng peptides in relation to full-length protein in brain tissue of patients with sporadic (sAD) and familial Alzheimer’s disease (fAD), healthy controls and individuals who were cognitively unaffected but amyloid-positive (CU-AP) in two different brain regions. Brain tissue from parietal cortex [sAD (n = 10) and age-matched controls (n = 10)] and temporal cortex [sAD (n = 9), fAD (n = 10), CU-AP (n = 13) and controls (n = 9)] were included and all the samples were analyzed by three different methods. Using high-resolution mass spectrometry, 39 endogenous Ng peptides were identified while full-length Ng was found to be modified including disulfide bridges or glutathione. In sAD parietal cortex, the ratio of peptide-to-total full-length Ng was significantly increased for eight endogenous Ng peptides compared to controls. In the temporal cortex, several of the peptide-to-total full-length Ng ratios were increased in both sAD and fAD cases compared to controls and CU-AP. This finding was confirmed by western blot, which mainly detects full-length Ng, and enzyme-linked immunosorbent assay, most likely detecting a mix of peptides and full-length Ng. In addition, Ng was significantly associated with the degree of amyloid and tau pathology. These results suggest that processing of Ng into peptides is increased in AD brain tissue, which may reflect the ongoing synaptic degeneration, and which is also mirrored as increased levels of Ng peptides in CSF.
引用
收藏
页码:89 / 102
页数:13
相关论文
共 50 条
  • [1] The intact postsynaptic protein neurogranin is reduced in brain tissue from patients with familial and sporadic Alzheimer's disease
    Kvartsberg, Hlin
    Lashley, Tammaryn
    Murray, Christina E.
    Brinkmalm, Gunnar
    Cullen, Nicholas C.
    Hoglund, Kina
    Zetterberg, Henrik
    Blennow, Kaj
    Portelius, Erik
    ACTA NEUROPATHOLOGICA, 2019, 137 (01) : 89 - 102
  • [2] Prion Protein is Reduced in Aging and in Sporadic but not in Familial Alzheimer's Disease
    Whitehouse, Isobel J.
    Jackson, Carolyn
    Turner, Anthony J.
    Hooper, Nigel M.
    JOURNAL OF ALZHEIMERS DISEASE, 2010, 22 (03) : 1023 - 1031
  • [3] Characterization of the postsynaptic protein neurogranin in paired cerebrospinal fluid and plasma samples from Alzheimer's disease patients and healthy controls
    Kvartsberg, Hlin
    Portelius, Erik
    Andreasson, Ulf
    Brinkmalm, Gunnar
    Hellwig, Konstantin
    Lelental, Natalia
    Kornhuber, Johannes
    Hansson, Oskar
    Minthon, Lennart
    Spitzer, Philipp
    Maler, Juan M.
    Zetterberg, Henrik
    Blennow, Kaj
    Lewczuk, Piotr
    ALZHEIMERS RESEARCH & THERAPY, 2015, 7
  • [4] Characterization of the postsynaptic protein neurogranin in paired cerebrospinal fluid and plasma samples from Alzheimer’s disease patients and healthy controls
    Hlin Kvartsberg
    Erik Portelius
    Ulf Andreasson
    Gunnar Brinkmalm
    Konstantin Hellwig
    Natalia Lelental
    Johannes Kornhuber
    Oskar Hansson
    Lennart Minthon
    Philipp Spitzer
    Juan M Maler
    Henrik Zetterberg
    Kaj Blennow
    Piotr Lewczuk
    Alzheimer's Research & Therapy, 7
  • [5] Comparison of Aβ levels in the brain of familial and sporadic Alzheimer's disease
    Hellstrom-Lindahl, E.
    Viitanen, M.
    Marutle, A.
    NEUROCHEMISTRY INTERNATIONAL, 2009, 55 (04) : 243 - 252
  • [6] Aluminium in brain tissue in familial Alzheimer's disease
    Mirza, Ambreen
    King, Andrew
    Troakes, Claire
    Exley, Christopher
    JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY, 2017, 40 : 30 - 36
  • [7] Brain metabolic differences between sporadic and familial Alzheimer's disease
    Mosconi, L
    Sorbi, S
    Nacmias, B
    De Cristofaro, MTR
    Fayyaz, M
    Cellini, E
    Bagnoli, S
    Bracco, L
    Herholz, K
    Pupi, A
    NEUROLOGY, 2003, 61 (08) : 1138 - 1140
  • [8] Biomarkers in Sporadic and Familial Alzheimer's Disease
    Lista, Simone
    O'Bryant, Sid E.
    Blennow, Kaj
    Dubois, Bruno
    Hugon, Jacques
    Zetterberg, Henrik
    Hampel, Harald
    JOURNAL OF ALZHEIMERS DISEASE, 2015, 47 (02) : 291 - 317
  • [9] Amyloid Imaging Findings in Familial and Sporadic Patients with Alzheimer's Disease
    Sanlier, M.
    Yilmaz, Y.
    Topcular, B.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 1030 - 1030
  • [10] Presenilin-1 protein expression in familial and sporadic Alzheimer's disease
    Levey, AI
    Heilman, CJ
    Lah, JJ
    Nash, NR
    Rees, HD
    Wakai, M
    Mirra, SS
    Rye, DB
    Nochlin, D
    Bird, TD
    Mufson, EJ
    ANNALS OF NEUROLOGY, 1997, 41 (06) : 742 - 753